Cargando…

Apoptosis and Molecular Targeting Therapy in Cancer

Apoptosis is the programmed cell death which maintains the healthy survival/death balance in metazoan cells. Defect in apoptosis can cause cancer or autoimmunity, while enhanced apoptosis may cause degenerative diseases. The apoptotic signals contribute into safeguarding the genomic integrity while...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hassan, Mohamed, Watari, Hidemichi, AbuAlmaaty, Ali, Ohba, Yusuke, Sakuragi, Noriaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075070/ https://www.ncbi.nlm.nih.gov/pubmed/25013758 http://dx.doi.org/10.1155/2014/150845

Ejemplares similares

P18/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxane
por: Hassan, Mohamed Kamel, et al.
Publicado: (2015)

Histone Deacetylase Inhibitors Sensitize Lung Cancer Cells to Hyperthermia: Involvement of Ku70/SirT-1 in Thermo-Protection
por: Hassan, Mohamed K., et al.
Publicado: (2014)

Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel
por: Hassan, Mohamed K, et al.
Publicado: (2011)

Nerve-sparing radical hysterectomy in the precision surgery for cervical cancer
por: Sakuragi, Noriaki, et al.
Publicado: (2020)

The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
por: Dong, Peixin, et al.
Publicado: (2014)

Emerging Therapeutic Biomarkers in Endometrial Cancer
por: Dong, Peixin, et al.
Publicado: (2013)

Chemotherapy and molecular targeting therapy for recurrent cervical cancer
por: Tsuda, Naotake, et al.
Publicado: (2016)

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1
por: Dong, Peixin, et al.
Publicado: (2011)

Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments
por: Mitamura, Takashi, et al.
Publicado: (2014)

miR-363 confers taxane resistance in ovarian cancer by targeting the Hippo pathway member, LATS2
por: Mohamed, Zeinab, et al.
Publicado: (2018)

microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway
por: Mitamura, Takashi, et al.
Publicado: (2014)

Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors
por: Dong, Peixin, et al.
Publicado: (2015)

MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells
por: Dong, Peixin, et al.
Publicado: (2016)

Oncological Outcomes After Okabayashi-Kobayashi Radical Hysterectomy for Early and Locally Advanced Cervical Cancer
por: Sakuragi, Noriaki, et al.
Publicado: (2020)

Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02)
por: Ohnishi, Shunsuke, et al.
Publicado: (2017)

Correction: microRNA 31 functions as an endometrial cancer oncogene by suppressing Hippo tumor suppressor pathway
por: Mitamura, Takashi, et al.
Publicado: (2014)

Multivariate survival analysis of the patients with recurrent endometrial cancer
por: Odagiri, Tetsuji, et al.
Publicado: (2011)

MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
por: Konno, Yosuke, et al.
Publicado: (2014)

Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer
por: Dong, Peixin, et al.
Publicado: (2018)

Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124
por: Dong, Peixin, et al.
Publicado: (2016)

Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy
por: Kato, Tatsuya, et al.
Publicado: (2013)

Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression
por: Dong, Peixin, et al.
Publicado: (2016)

Correction: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer
por: Dong, Peixin, et al.
Publicado: (2019)

EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis
por: Ihira, Kei, et al.
Publicado: (2017)

Concurrent chemoradiotherapy for cervical cancer: background including evidence-based data, pitfalls of the data, limitation of treatment in certain groups
por: Todo, Yukiharu, et al.
Publicado: (2016)

Adjuvant chemotherapy for early-stage cervical cancer
por: Asano, Hiroshi, et al.
Publicado: (2016)

Emerging concept of tailored lymphadenectomy in endometrial cancer
por: Sakuragi, Noriaki
Publicado: (2012)

Molecular-Targeted Therapies for Epidermal Growth Factor Receptor and Its Resistance Mechanisms
por: Yamaoka, Toshimitsu, et al.
Publicado: (2017)

Nerve-sparing radical hysterectomy: time for a new standard of care for cervical cancer?
por: Sakuragi, Noriaki
Publicado: (2015)

Status of the Current Treatment Options and Potential Future Targets in Uterine Leiomyosarcoma: A Review
por: Asano, Hiroshi, et al.
Publicado: (2022)

Retracted: Apoptosis and Molecular Targeting Therapy in Cancer
por: International, BioMed Research
Publicado: (2020)

The Expression, Functions and Mechanisms of Circular RNAs in Gynecological Cancers
por: Dong, Peixin, et al.
Publicado: (2020)

Long Non-coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors
por: Dong, Peixin, et al.
Publicado: (2018)

Receptor Tyrosine Kinase-Targeted Cancer Therapy
por: Yamaoka, Toshimitsu, et al.
Publicado: (2018)

The prognosis of endometrial cancers stratified with conventional risk factors and modified molecular classification
por: Yamazaki, Hiroyuki, et al.
Publicado: (2022)

Crosstalk Between Apoptosis and Autophagy: Molecular Mechanisms and Therapeutic Strategies in Cancer
por: El-Khattouti, Abdelouahid, et al.
Publicado: (2013)

Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study
por: Zhai, Tianyue, et al.
Publicado: (2023)

B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
por: Dong, Peixin, et al.
Publicado: (2018)

Nomad Jellyfish Rhopilema nomadica Venom Induces Apoptotic Cell Death and Cell Cycle Arrest in Human Hepatocellular Carcinoma HepG2 Cells
por: Tawfik, Mohamed M., et al.
Publicado: (2021)

Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges
por: Dong, Peixin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_38ovpdel0a9ouhnensch42obf5